Reuters - Bayer HealthCare, a U.S.-based unit of Bayer AG
, stopped a late-stage trial of Nexavar in patients
with non-small cell lung cancer, after an independent data
monitoring committee concluded that the study would not meet
the main goal of improved overall survival.
No comments:
Post a Comment